Halozyme Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -58.36M-53.24M-19.77M-53.55M-83.48M-68.38M-32.23M-103.02M62.97M-80.33M-72.24M129.09M402.71M202.13M281.59M444.09M
Share-based Compensation 4.53M4.87M5.57M8.35M9.54M15.27M20.84M25.59M30.67M35.70M34.78M17.20M20.82M24.40M36.62M43.38M
Deferred Taxes 155.43M-40.01M-34.51M-0.53M
Gains from Investment Securities -0.00M-0.01M0.00M1.45M1.45M-0.23M0.44M-0.01M-0.05M2.83M4.00M4.12M1.50M34.44M31.76M80.62M
Asset Writedowns and Impairment 1.13M0.58M
Cash from Operations -40.15M-45.39M-34.30M-64.28M-49.34M-47.52M-37.08M-50.38M134.05M-49.50M-85.42M55.45M299.44M240.11M388.57M479.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -1.12M-1.46M-13.18M0.30M3.09M2.48M14.14M3.64M43.15M73.77M71.05M
Amortization of Deferred Charges 0.01M0.16M2.02M1.24M2.90M1.76M1.54M
Depreciation & Amortization (CF) 1.44M1.51M1.10M1.08M1.23M1.76M1.70M2.41M2.20M2.40M4.10M3.30M3.00M6.50M11.10M10.30M
Change in Working Capital
Change in Receivables -3.02M-1.92M-0.07M13.44M-6.61M0.05M23.26M-16.73M6.45M-11.61M29.44M38.29M-6.75M83.94M3.34M74.25M
Change in Inventory 0.72M-0.97M0.37M2.10M3.50M0.24M3.08M5.13M-9.48M17.48M6.73M31.39M-7.37M17.48M26.88M67.38M
Change in Accured Expenses -2.00M3.44M0.71M-3.26M7.89M-0.82M13.87M-0.24M15.63M5.70M4.64M-41.21M1.17M24.54M-12.55M46.99M
Other Working Capital Changes 11.03M-2.39M-17.21M4.42M9.30M7.04M15.77M-5.63M22.76M5.70M19.01M4.63M11.55M9.06M-4.10M-5.36M
Investing Activities
Capital Expenditures 1.46M0.65M0.83M1.41M2.30M1.37M2.36M3.14M1.35M4.66M4.04M2.50M1.46M6.23M15.29M10.70M
Sales of Property, Plant and Equipment 1.08M26.01M
Acquisitions 999.12M
Change in Acquisitions & Divestments 3.38M57.30M79.73M81.78M235.81M318.27M388.25M305.97M247.68M746.13M211.30M395.57M
Cash from Investing Activities -1.46M-0.65M-0.83M-1.41M-47.87M-32.95M5.89M-76.77M-163.73M2.49M-5.55M78.35M-406.29M-487.00M-96.91M-262.72M
Financing Activities
Other financing activities 0.28M0.42M7.10M
Cash from Financing Activities 45.36M61.82M4.75M112.82M25.06M114.50M13.10M150.62M131.66M-63.80M153.22M-106.28M77.86M362.37M-407.99M-218.86M
Additional items
Change in Cash 3.75M15.79M-30.38M47.13M-72.14M34.03M-18.10M23.47M101.98M-110.80M62.24M27.52M-28.98M115.48M-116.33M-2.52M
Free Cash Flow -41.61M-46.03M-35.13M-65.69M-51.64M-48.89M-39.44M-53.52M132.70M-54.16M-89.46M52.95M297.98M233.88M373.28M468.37M
Net Cash Flow 3.75M15.79M-30.38M47.13M-72.14M34.03M-18.10M23.47M101.98M-110.80M62.24M27.52M-28.98M115.48M-116.33M-2.52M